LOXL2 and prostate neoplasm: Using a proteomic strategy based on this concept, our global proteomic analysis of CAF established from primary prostate tumors identified a prominent protein-protein interaction hub centered on the DDR2-collagen-LOXL2 signaling axis, critical for ECM remodeling and function (62, 68, 69).